quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:15:00·3d
PRRelease
Clearmind Medicine Inc. logo

Clearmind Medicine Announced Positive Top-Line Safety Results: CMND-100 Proprietary Psychedelic Treatment Meets Primary Endpoint in AUD Trial

CMND· Clearmind Medicine Inc.
Health Care
Original source

Companies

  • CMND
    Clearmind Medicine Inc.
    Health Care

Related

  • SEC2d
    SEC Form 6-K filed by Clearmind Medicine Inc.
  • SEC3d
    SEC Form 6-K filed by Clearmind Medicine Inc.
  • SEC3d
    SEC Form 6-K filed by Clearmind Medicine Inc.
  • PR3d
    Clearmind Medicine Welcomes President Trump's Executive Order as a Historic Catalyst for Psychedelic Innovation and Veteran Mental Health Care
  • SEC8d
    SEC Form 6-K filed by Clearmind Medicine Inc.
  • PR8d
    Clearmind Medicine Announces Positive Data Safety Monitoring Board Recommendation in ongoing CMND-100 clinical trial
  • SEC8d
    SEC Form 6-K filed by Clearmind Medicine Inc.
  • SEC9d
    SEC Form 6-K filed by Clearmind Medicine Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022